**Online Registration is now closed. Onsite Registration will be available. **
BioHouston Members: $30
Non Members: $40
Students: $20
Registration & Networking: 7:30 am Breakfast & Program: 8:00 am – 9:00 am
Please join hosts BioHouston, Ernst & Young, and Rice Alliance for an interactive discussion of this year’s edition of the Beyond Borders Report. This report demonstrates how much the biotech industry has prospered over the last 30 years, due to a combination of extraordinary scientific progress and innovative business modeling. In 2015, the industry set numerous dealmaking and financial performance records as total market capitalization eclipsed the US$1 trillion threshold for the second year in a row.
Key highlights to include:
R&D spending, a key indicator of the future health of the sector, outpaced the sector’s revenue growth, increasing 16% in 2015 to US$40.1b.
The year’s 89 biotechnology M&A deals represented a 10-year high. The cumulative deal value jumped 120% from the previous year to US$100.2b; close to the combined value of the previous three years.
The potential value of strategic alliances reached US$55.4b in 2015, a new record driven by 17 individual alliances valued at more than US$1b.
SPEAKER Glen Giovannetti, Global Biotechnology Leader, Research & Insights Leader, Ernst & Young
Glen Giovannetti has been focused on the life sciences sector for over 23 years and is the EY’s former global life sciences sector leader. Glen is currently EY’s global biotechnology leader as part of the life sciences sector team, and research and insights leader as part of the knowledge team.
As global biotechnology leader, he works to enhance EY’s services to biotechnology clients and create unique points of view on the industry trends and drivers. As research and insights leader, he leads a team of over 300 knowledge professionals aligned to all of EY’s sectors, service lines and locations.
Glen is an assurance partner and previously led the risk advisory practice for EY. Glen is a past member of the board of directors of the Biotechnology Industry Organization, a member of the Leadership Council of The Schwartz Center for Compassionate Care at Massachusetts General Hospital, a member of the Board of Director of Life Sciences Cares and serves on the Board of Trustees of Linfield College.